MD Anderson Researchers Present Encouraging Results of Early-Stage Clinical Trials at 2022 American Society of Clinical Oncology Annual Meeting
June 08, 2022
June 08, 2022
CHICAGO, Illinois, June 8 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release on June 7, 2022:
Results from three early-stage clinical trials led by researchers at The University of Texas MD Anderson Cancer Center show promising activity with novel immunotherapies and targeted therapies for patients with advanced tumors.
The findings, presented today at the 2022 American Society of Clinical Oncology (ASCO) Annual Meetin . . .
Results from three early-stage clinical trials led by researchers at The University of Texas MD Anderson Cancer Center show promising activity with novel immunotherapies and targeted therapies for patients with advanced tumors.
The findings, presented today at the 2022 American Society of Clinical Oncology (ASCO) Annual Meetin . . .